Montecito Bank & Trust’s Avanos Medical AVNS Stock Holding History

Montecito Bank & Trust’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-208	Closed	-$8K	–	196
2016 Q4	$8K	Buy	+208	New	+$7.43K	﹤0.01%	363

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Montecito Bank & Trust's AVNS Position: Q1 2017 in Review

Montecito Bank & Trust sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 208 shares — an estimated $8K sold.

Montecito Bank & Trust first reported a position in AVNS in Q4 2016 and held it in 1 quarter. The position peaked at $8K in Q4 2016. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

Montecito Bank & Trust reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
Montecito Bank & Trust sold 208 Avanos Medical shares in Q1 2017, an estimated $8K.
Montecito Bank & Trust first reported a position in Avanos Medical in Q4 2016 and held it in 1 quarter.
Montecito Bank & Trust's Avanos Medical position peaked at $8K in Q4 2016.
335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on Montecito Bank & Trust's 13F filing for Q1 2017, filed 5 May 2017.